Budgeting 101 Why Kymera Therapeutics Stock Crushed it This WeekBy Dan Brown26/04/20250 According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics (KYMR -0.86%) notched an almost 23% share price gain…
